BMKCloud Log in

About Us

Biomarker Technologies (BMK)

Biomarker Technologies(BMKGENE), as one of the leading provider of genomics services, is founded in 2009, headquartered in Beijing, China. BMKGENE has been actively engaged in innovation and development of high-throughput sequencing technologies and bioinformatics for over 14 years. Its business consists of science and technology services and BioCloud bioinformatics platform. BMKGENE has established long-term cooperation with various organizations, including universities, hospitals, research institutes, independent laboratories, pharmaceutical companies, plant breeding companies, medical and health institutes, etc., sitting in over 50 regions all over the world.

To innovate biotechnology

To Serve the society

To Benefit people

To create innovative biotechnology center and establish a symbolic enterprise in bio-industry

Our Advantages

Biomarker Technologies owns a passionate and highly-skilled R&D team of over 500 members composed of highly-educated technical staff, senior engineers, bioinformaticians and experts in diverse areas including biotechnology, agriculture, medicine, computing, etc. Our outstanding technical team has robust ability in tackling scientific and technical issues and has accumulated massive experience in diverse research area and contributed in hundreds of high-impact publications in Nature, Nature Genetics, Nature Communications, Plant Cell, etc. It owns over 60 nation patents of inventions and 200 software copyrights.

Main Business

Science and Technology Services

Providing over 60 comprehensive high-throughput biological measurements and bioinformatics services, covering genomics, transcriptomics, epigenetics, single-cell omics, proteomics, metabolomics, etc.

On-line Bioinformatics Platform

Providing efficient, safe and ease-to-use online bioinformatics analysis platform containing innovative customized analyzing tools, databases at PB-level, chatting section, training materials, etc.

Our Platforms


Leading, Multi-level High-throughput Sequencing Platforms

PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5 MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
QTRAP 6500+


Professional, Automatic Molecular Laboratory

Over 20,000 square feet place

Advanced biomolecular laboratory instruments

Standard labs of sample extraction, library construction, clean rooms, sequencing labs

Standard procedures from sample extraction to sequencing under strict SOPs


Multiple and flexible experimental designs fulfilling diverse research goals

Reliable, Ease-to-use On-line Bioinformatic Analysis Platform

Self-developed BMKCloud platform

CPUs with 41,104 memory and 3 PB total storage

4,260 computing cores with peak computing power over 121,708.8 Gflop per second.

Contact Us

Biomarker Technologies owns the most cutting-edge high-throughput sequencing platforms and high-performance computing platforms, serving for next-generation sequencing, third-generation sequencing, single-cell multiomics, proteomics, metabolomics and high-throughput data handling. Biomarker Technologies is committed to continuously creat greater value for its customers and lead the industrial transformation with high-quality innovations to realize its ultimate mission of benefiting humanity with genetic technology.

get a quote

Write your message here and send it to us

Send your message to us: